ClinicalTrials.Veeva

Menu

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

A

Asfendiyarov Kazakh National Medical University

Status

Completed

Conditions

Hemorrhagic Stroke
Eclampsia

Treatments

Genetic: SNP analysis of the DNA

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To search for a genetic marker of hemorrhagic stroke complicating severe eclampsia, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with hemorrhagic stroke and normal control will be performed.

Full description

Detailed Description:

Unrelated Korean subjects who have Spontaneous hemorrhagic stroke complicating severe eclampsia in pregnancy were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with hemorrhagic stroke and normal control subjects free of hemorrhagic stroke

Enrollment

100 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-patients with hemorrhagic stroke complicating severe eclampsia in pregnancy

Exclusion criteria

patients without hemorrhagic stroke complicating severe eclampsia in pregnancy

Trial design

100 participants in 2 patient groups

Experimental group:
Description:
patients with hemorrhagic stroke complicating severe pre-eclampsia in pregnancy
Treatment:
Genetic: SNP analysis of the DNA
Control group
Description:
patients without hemorrhagic stroke complicating severe pre-eclampsia in pregnancy
Treatment:
Genetic: SNP analysis of the DNA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems